NSPR - InspireMD, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD

InspireMD, Inc.

4 Menorat Hamaor Street
Tel Aviv 6744832
Israel
972 3 6917691
http://www.inspire-md.com

SectorHealthcare
IndustryMedical Devices
Full Time Employees36

Key Executives

NameTitlePayExercisedYear Born
Dr. James J. Barry Ph.D.Pres, CEO & Director421.24kN/A1959
Mr. Craig ShoreCFO, Chief Admin. Officer, Treasurer & Sec.435.68kN/A1961
Mr. Agustin V. GagoExec. VP & Chief Commercial Officer76.22kN/A1960
Dr. Sol J. BarerSpecial Advisor to the Board17.5kN/A1947
Mr. Benzi SpectorHead of R&D and OperationsN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of coronary and vascular diseases. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions. It is also developing NGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms in order to seal the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.

Corporate Governance

InspireMD, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.